[The adiponectin to leptin ratio, a still unrecognized biomarker of insulin resistance and cardiometabolic risk]

Ann Biol Clin (Paris). 2020 Jun 1;78(3):265-268. doi: 10.1684/abc.2020.1559.
[Article in French]

Abstract

Leptin and adiponectin are two adipokines. Their circulating concentrations, high for leptin and low for adiponectin, are predictive of insulin resistance and of an unfavorable cardiometabolic evolution in patients with obesity, metabolic syndrome or type 2 diabetes. In addition, recently, the adiponectin/leptin ratio has been proposed as an index of adipose tissue dysfunction together with threshold values for cardiometabolic risk for this index. The relevance and potential applications of the adiponectin/leptin and leptin/adiponectin ratios are discussed in the light of recent literature in this brief update.

Keywords: adiponectin; adiponectin/leptin ratio; insulin resistance; leptin; obesity.

Publication types

  • Review

MeSH terms

  • Adiponectin / analysis
  • Adiponectin / blood*
  • Biomarkers / analysis
  • Biomarkers / blood*
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / etiology*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / metabolism
  • Diagnostic Techniques, Endocrine*
  • Humans
  • Insulin Resistance*
  • Leptin / analysis
  • Leptin / blood*
  • Metabolic Syndrome / complications
  • Metabolic Syndrome / diagnosis
  • Metabolic Syndrome / metabolism
  • Obesity / complications
  • Obesity / diagnosis
  • Obesity / metabolism
  • Prognosis
  • Risk Factors

Substances

  • Adiponectin
  • Biomarkers
  • Leptin